Kaketsuken-Like Cases Seen Outside Japan Too, Many Exposed through Tip-Offs: PMDA

PMDA committee on review and safety operations Regulatory authorities in major markets outside Japan have seen drug makers commit data cover-ups and record tampering, like Kaketsuken’s GMP violation case in Japan, with many laid bare by whistleblowers, according to the...read more